Formulations for use in medical or diagnostic procedures

Details for Australian Patent Application No. 2002365395 (hide)

Owner E-Z-EM, Inc.

Inventors Schneeman, Hubert; Debatin, Jorg F; Lauenstein, Thomas C

Agent Spruson & Ferguson

Pub. Number AU-B-2002365395

PCT Number PCT/US02/37385

PCT Pub. Number WO2003/045308

Priority 60/332,074 21.11.01 US

Filing date 21 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 20 July 2006

International Classifications

A61K 49/00 (2006.01) Preparations for testing

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/332,074 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002365395

20 July 2006 Application Accepted

  Published as AU-B-2002365395

30 November 2006 Standard Patent Sealed

18 December 2008 Assignment Registered

  E-Z-EM, Inc. The patent has been assigned to Bracco Diagnostics Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365396-COMPOUNDS THAT BIND TO P185 AND METHODS OF USING THE SAME

2002365394-PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHEN OLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHEN OLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIP HENOLS